Prognostic Role of Platelet to Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
Author(s) -
Arnoud J. Templeton,
Olga Ace,
Mairéad G. McNamara,
Mustafa Al-Mubarak,
Francisco Vera-Badillo,
Thomas Hermanns,
Boštjan Šeruga,
Alberto Ocaña,
Ian F. Tannock,
Eitan Amir
Publication year - 2014
Publication title -
cancer epidemiology biomarkers and prevention
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.234
H-Index - 192
eISSN - 1538-7755
pISSN - 1055-9965
DOI - 10.1158/1055-9965.epi-14-0146
Subject(s) - medicine , meta analysis , confidence interval , gastroenterology , hepatocellular carcinoma , biomarker , oncology , lymphocyte , disease , biochemistry , chemistry
Inflammation influences cancer development and progression. An elevated platelet to lymphocyte ratio (PLR), a marker of inflammation, has been linked to poor prognosis in several malignancies. Here, we quantify the prognostic impact of this biomarker.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom